hrcak mascot   Srce   HID

Izvorni znanstveni članak
https://doi.org/10.1515/bsrj-2016-0002

The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances

Patrik Vida   ORCID icon orcid.org/0000-0003-0127-7178 ; Faculty for Commercial and Business Sciences, Celje, Slovenia

Puni tekst: engleski, pdf (591 KB) str. 16-34 preuzimanja: 414* citiraj
APA 6th Edition
Vida, P. (2016). The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances. Business Systems Research, 7 (1), 16-34. https://doi.org/10.1515/bsrj-2016-0002
MLA 8th Edition
Vida, Patrik. "The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances." Business Systems Research, vol. 7, br. 1, 2016, str. 16-34. https://doi.org/10.1515/bsrj-2016-0002. Citirano 20.06.2021.
Chicago 17th Edition
Vida, Patrik. "The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances." Business Systems Research 7, br. 1 (2016): 16-34. https://doi.org/10.1515/bsrj-2016-0002
Harvard
Vida, P. (2016). 'The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances', Business Systems Research, 7(1), str. 16-34. https://doi.org/10.1515/bsrj-2016-0002
Vancouver
Vida P. The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances. Business Systems Research [Internet]. 2016 [pristupljeno 20.06.2021.];7(1):16-34. https://doi.org/10.1515/bsrj-2016-0002
IEEE
P. Vida, "The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances", Business Systems Research, vol.7, br. 1, str. 16-34, 2016. [Online]. https://doi.org/10.1515/bsrj-2016-0002

Sažetak
Background: Biotechnology is rapidly developing on a global scale. However, some evidence indicates that Eastern European (EE) countries are not fulfilling their potential in this field. Objectives: This paper aims to examine whether selected EE countries are able to develop a strong biotechnology industry. Potential investment approaches and the existing but not used or neglected infrastructures in EE countries were also examined. Methods/approach: In order to determine biotechnological activities in EE countries, indicators such as intellectual property protection, venture capital availability, published scientific publications as well as other indicators were analyzed. These indicators were compiled and compared between EE countries and regions with a rich and diverse biotechnological business sector. Results: The results suggest an underdeveloped biotechnology business sector in EE countries, with talented but unexploited scientists and unutilized infrastructure. The systematic drawbacks of EE countries lead to a hostile investment environment. Conclusions: The findings make a significant contribution to understanding how the biotechnology industry in EE countries is structured and how investments can be rationally placed. EE countries need to adapt their venture capital market for biotechnology ventures. Several changes in regulations could have a large impact on biotechnology investments.

Ključne riječi
biotechnology; investment; research and development; transition countries; Eastern Europe

Hrčak ID: 158298

URI
https://hrcak.srce.hr/158298

Posjeta: 668 *